Picture of PolyPeptide AG logo

PPGN PolyPeptide AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Polypeptide Group Ag - Full Year Revenue Eur 389 Million

Jan 19 (Reuters) - PolyPeptide Group AG PPGN.S:

POLYPEPTIDE SUCCESSFULLY CLOSES FINANCIAL YEAR 2025 WITH STRONG REVENUE GROWTH AND MARKED IMPROVEMENT IN PROFITABILITY

POLYPEPTIDE GROUP AG - FY REVENUE EUR 389 MILLION, GROWTH RATE +15.6%

POLYPEPTIDE GROUP AG - REAFFIRMS ITS MID‑TERM TARGETS TO DOUBLE REVENUE REPORTED FOR 2023 BY 2028

POLYPEPTIDE GROUP AG - CAPITAL EXPENDITURES EXPECTED OVER EUR 100 MILLION

POLYPEPTIDE GROUP AG - 2025 REACHING BETWEEN 11 - 12% EBITDA MARGIN TOWARDS UPPER END OF GUIDANCE AND UP FROM 7.5% IN 2024

Source text: ID:nEQspyHMa

Further company coverage: PPGN.S

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))

Recent news on PolyPeptide AG

See all news